InterStim Procedure for Fecal Incontinence
Sacral nerve stimulation (InterStim) is a safe and effective treatment option for patients with moderate to severe fecal incontinence who have failed conservative measures and biofeedback therapy. 1
What is the InterStim Procedure?
The InterStim procedure involves sacral nerve stimulation (SNS) to treat fecal incontinence through electrical modulation of the sacral nerves that control bowel function. It is a minimally invasive surgical approach that consists of two phases:
Test Phase (Phase I):
- Temporary percutaneous placement of a lead near the S3 sacral nerve
- Test period of at least 14 days to evaluate effectiveness
- Success defined as ≥50% reduction in fecal incontinence episodes
Permanent Implantation (Phase II):
- Implantation of a permanent neurostimulator device
- Typically performed under local anesthesia as an outpatient procedure
- Involves placement of a small pulse generator in the upper buttock region
Effectiveness and Outcomes
InterStim therapy has demonstrated significant clinical benefits:
- Success rate: 88-90% of patients who undergo test stimulation qualify for permanent implantation 2, 3
- Symptom reduction: 83-86% of patients achieve ≥50% reduction in incontinent episodes at 12-36 months 4, 3
- Complete continence: Achieved in 40-41% of patients 4, 3
- Long-term efficacy: Benefits maintained for at least 3 years in follow-up studies 4
Patient Selection
InterStim is indicated for patients who meet the following criteria:
- Moderate to severe fecal incontinence (typically >2 episodes per week)
- Failed conservative management including:
- Dietary modifications
- Fiber supplementation
- Bowel training programs
- Anti-diarrheal medications
- Failed pelvic floor retraining with biofeedback therapy (3-month minimum trial)
- No contraindications to the procedure 1, 5
Stepwise Approach to Fecal Incontinence Management
InterStim therapy should be considered within a stepwise approach:
- First-line: Conservative measures (dietary modifications, medications, bowel training)
- Second-line: Pelvic floor biofeedback therapy
- Third-line: Minimally invasive interventions:
- Perianal bulking agents (e.g., dextranomer injection)
- Sacral nerve stimulation (InterStim)
- Fourth-line: More invasive surgical options:
Safety Profile
The InterStim procedure has a favorable safety profile:
- Common side effects: Implant site pain (28%), paresthesia (15%), changes in stimulation sensation (12%) 4
- Infection rate: Approximately 10% 4
- Device removal: Rarely needed, typically for chronic pain or infection
- No reported unanticipated adverse device effects 4, 3
Advantages Over Traditional Surgical Approaches
InterStim offers several advantages over traditional surgical approaches:
- Less invasive than sphincteroplasty or artificial sphincter placement
- Reversible procedure
- Test phase allows prediction of success before permanent implantation
- Outpatient procedure with minimal recovery time
- Lower morbidity compared to traditional surgical approaches 2
Common Pitfalls to Avoid
- Premature progression to surgical intervention before adequate trials of conservative therapy and biofeedback
- Failure to identify and treat underlying causes of fecal incontinence (e.g., diarrhea, evacuation disorders)
- Inadequate patient selection - best results occur in patients who have truly failed conservative measures
- Not addressing anatomic defects - major defects like rectovaginal fistula or rectal prolapse should be surgically corrected before considering InterStim 1, 5
InterStim therapy represents an important advancement in the treatment of fecal incontinence, offering a minimally invasive option with demonstrated long-term efficacy for patients who have failed conservative management approaches.